275 related articles for article (PubMed ID: 30655107)
1. Nanoparticle-mediated local delivery of pioglitazone attenuates bleomycin-induced skin fibrosis.
Kanemaru M; Asai J; Jo JI; Arita T; Kawai-Ohnishi M; Tsutsumi M; Wada M; Tabata Y; Katoh N
J Dermatol Sci; 2019 Jan; 93(1):41-49. PubMed ID: 30655107
[TBL] [Abstract][Full Text] [Related]
2. Octreotide ameliorates dermal fibrosis in bleomycin-induced scleroderma.
Oyucu Orhan S; Tektemur A; Gözel N; Özercan İH; Yolbaş S; Yıldırım A; Önalan E; Koca SS
Turk J Med Sci; 2018 Aug; 48(4):886-891. PubMed ID: 30121056
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.
Tokutome M; Matoba T; Nakano Y; Okahara A; Fujiwara M; Koga JI; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Feb; 115(2):419-431. PubMed ID: 30084995
[TBL] [Abstract][Full Text] [Related]
4. A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.
Wei J; Zhu H; Komura K; Lord G; Tomcik M; Wang W; Doniparthi S; Tamaki Z; Hinchcliff M; Distler JH; Varga J
Ann Rheum Dis; 2014 Feb; 73(2):446-54. PubMed ID: 23515440
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.
Wu M; Melichian DS; Chang E; Warner-Blankenship M; Ghosh AK; Varga J
Am J Pathol; 2009 Feb; 174(2):519-33. PubMed ID: 19147827
[TBL] [Abstract][Full Text] [Related]
6. Mouse model of dermal fibrosis induced by one-time injection of bleomycin-poly(L-lactic acid) microspheres.
Shibusawa Y; Negishi I; Tabata Y; Ishikawa O
Rheumatology (Oxford); 2008 Apr; 47(4):454-7. PubMed ID: 18316335
[TBL] [Abstract][Full Text] [Related]
7. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
8. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis.
Aoki Y; Maeno T; Aoyagi K; Ueno M; Aoki F; Aoki N; Nakagawa J; Sando Y; Shimizu Y; Suga T; Arai M; Kurabayashi M
Respiration; 2009; 77(3):311-9. PubMed ID: 18974632
[TBL] [Abstract][Full Text] [Related]
10. Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma.
Diddi S; Bale S; Pulivendala G; Godugu C
Inflammopharmacology; 2019 Feb; 27(1):139-149. PubMed ID: 30218238
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma.
Zhou CF; Yu JF; Zhang JX; Jiang T; Xu SH; Yu QY; Zhu QX
Clin Exp Dermatol; 2013 Jun; 38(4):403-9. PubMed ID: 23517443
[TBL] [Abstract][Full Text] [Related]
12. Withaferin A attenuates bleomycin-induced scleroderma by targeting FoxO3a and NF-κβ signaling: Connecting fibrosis and inflammation.
Bale S; Pulivendala G; Godugu C
Biofactors; 2018 Nov; 44(6):507-517. PubMed ID: 30367690
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
Nagahama R; Matoba T; Nakano K; Kim-Mitsuyama S; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2427-34. PubMed ID: 22879581
[TBL] [Abstract][Full Text] [Related]
14. Antifibrotic therapy by sustained release of low molecular weight heparin from poly(lactic-co-glycolic acid) microparticles on bleomycin-induced pulmonary fibrosis in mice.
Saito T; Kotani T; Suzuki K
Sci Rep; 2020 Nov; 10(1):19019. PubMed ID: 33149192
[TBL] [Abstract][Full Text] [Related]
15. The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.
del Río C; Navarrete C; Collado JA; Bellido ML; Gómez-Cañas M; Pazos MR; Fernández-Ruiz J; Pollastro F; Appendino G; Calzado MA; Cantarero I; Muñoz E
Sci Rep; 2016 Feb; 6():21703. PubMed ID: 26887982
[TBL] [Abstract][Full Text] [Related]
16. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy.
Fang F; Liu L; Yang Y; Tamaki Z; Wei J; Marangoni RG; Bhattacharyya S; Summer RS; Ye B; Varga J
Arthritis Res Ther; 2012 Oct; 14(5):R229. PubMed ID: 23092446
[TBL] [Abstract][Full Text] [Related]
17. PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies.
Silva-Abreu M; Calpena AC; Andrés-Benito P; Aso E; Romero IA; Roig-Carles D; Gromnicova R; Espina M; Ferrer I; García ML; Male D
Int J Nanomedicine; 2018; 13():5577-5590. PubMed ID: 30271148
[TBL] [Abstract][Full Text] [Related]
18. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
[TBL] [Abstract][Full Text] [Related]
20. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
